My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Norditropin NordiFlex 15 mg/1.5 ml solution for injection in pre-filled pen



Novo Nordisk A/SPA0218/040/010

Main Information

Trade NameNorditropin NordiFlex 15 mg/1.5 ml solution for injection in pre-filled pen
Active SubstancesSomatropin
Dosage FormSolution for injection in pre-filled pen
Licence HolderNovo Nordisk A/S
Licence NumberPA0218/040/010

Group Information

ATC CodeH01AC Somatropin and somatropin agonists
H01AC01 somatropin

Status

License statusAuthorised
Licence Issued10/09/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print